EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 49 filers reported holding EVELO BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,000 | -55.6% | 12,930 | -20.9% | 0.00% | – |
| Q4 2021 | $99,000 | -13.9% | 16,344 | 0.0% | 0.00% | – |
| Q3 2021 | $115,000 | -80.0% | 16,344 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $576,000 | +54.8% | 41,923 | +20.7% | 0.00% | – |
| Q1 2021 | $372,000 | +1.6% | 34,735 | +14.8% | 0.00% | -100.0% |
| Q4 2020 | $366,000 | +218.3% | 30,268 | +38.7% | 0.00% | – |
| Q3 2020 | $115,000 | +7.5% | 21,824 | 0.0% | 0.00% | – |
| Q2 2020 | $107,000 | +30.5% | 21,824 | 0.0% | 0.00% | – |
| Q1 2020 | $82,000 | -6.8% | 21,824 | +1.1% | 0.00% | – |
| Q4 2019 | $88,000 | -33.3% | 21,579 | 0.0% | 0.00% | – |
| Q3 2019 | $132,000 | -32.0% | 21,579 | 0.0% | 0.00% | – |
| Q2 2019 | $194,000 | +12.1% | 21,579 | 0.0% | 0.00% | – |
| Q1 2019 | $173,000 | -38.4% | 21,579 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $281,000 | +181.0% | 21,579 | +163.0% | 0.00% | – |
| Q3 2018 | $100,000 | +3.1% | 8,206 | 0.0% | 0.00% | – |
| Q2 2018 | $97,000 | – | 8,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $37,038,000 | 14.47% |
| Mayo Clinic | 484,953 | $5,863,000 | 7.05% |
| Flagship Pioneering Inc. | 22,900,069 | $276,862,000 | 5.04% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,376,000 | 1.84% |
| Alphabet Inc. | 1,060,495 | $12,821,000 | 0.62% |
| Artal Group S.A. | 700,000 | $8,463,000 | 0.18% |
| Larson Financial Group LLC | 28,353 | $343,000 | 0.12% |
| PEDDOCK CAPITAL ADVISORS, LLC | 3,663 | $44,000 | 0.02% |
| CREDIT SUISSE AG/ | 2,705,511 | $32,710,000 | 0.02% |
| FMR LLC | 6,803,365 | $82,253,000 | 0.01% |